Is a nasal inferior fracture (CPT 30930) medically necessary for a patient with epiphora (excessive tearing) due to acquired stenosis of the nasolacrimal duct?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Necessity Determination for CPT 30930 (Inferior Turbinate Fracture)

CPT 30930 (inferior turbinate fracture) is NOT medically necessary for this patient with epiphora due to acquired nasolacrimal duct stenosis, as the effectiveness of inferior turbinate fracture for managing nasolacrimal duct obstruction has not been established and is considered unproven.

Rationale Based on Clinical Policy

The clinical policy bulletin explicitly states that inferior turbinate fracture for the management of nasolacrimal duct obstruction is considered unproven because effectiveness has not been established. This applies to both congenital and acquired nasolacrimal duct obstruction, making it inappropriate for this 58-year-old patient with acquired stenosis.

Appropriate Procedures for This Patient

The following procedures ARE medically necessary and supported by evidence for acquired nasolacrimal duct obstruction with epiphora:

CPT 68815 (Probe Nasolacrimal Duct) - APPROVED

  • Balloon dacryocystoplasty is medically necessary for epiphora due to acquired obstruction within the nasolacrimal sac and duct 1, 2
  • Long-term primary patency rates of 70% have been demonstrated, with secondary patency rates of 81% after repeat procedures 3
  • This minimally invasive approach preserves normal anatomy and avoids facial scarring 1

CPT 68720 (Dacryocystorhinostomy/DCR) - APPROVED

  • DCR remains the gold standard with 85-95% success rates for nasolacrimal duct obstruction 4
  • Indicated when balloon dacryocystoplasty fails or is contraindicated 3
  • Should be considered as the definitive procedure if less invasive approaches are unsuccessful 5

CPT 31231 (Nasal Endoscopy) - APPROVED

  • May be certified for evaluation and surgical planning in this context
  • Useful for assessing nasal anatomy and potential endonasal surgical approaches

Clinical Context and Pitfalls

Key considerations:

  • The patient has constant tearing since the documented date, indicating significant functional impairment requiring intervention 1, 2
  • Inferior turbinate fracture has no established role in the treatment pathway for nasolacrimal duct obstruction
  • The appropriate treatment algorithm is: probe/balloon dacryocystoplasty first, followed by DCR if initial treatment fails 3

Common pitfall to avoid:

  • Do not confuse inferior turbinate procedures (which address nasal airway obstruction) with nasolacrimal duct procedures (which address tear drainage). These are anatomically and functionally distinct systems. Inferior turbinate fracture does not improve nasolacrimal drainage 1, 2, 3

Recommended Treatment Sequence

  1. Initial intervention: Balloon dacryocystoplasty (CPT 68815) with possible stent placement
  2. If initial treatment fails: External DCR (CPT 68720) with silicone intubation 5
  3. Adjunctive: Nasal endoscopy (CPT 31231) for surgical planning and assessment

The plan to "probe and irrigate stent, possible DCR" is appropriate and evidence-based, but CPT 30930 should be removed from the authorization request as it serves no therapeutic purpose for this indication 1, 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.